Corey Murphy

Corey Murphy has extensive experience in regulatory affairs, currently serving in a regulatory role at Rapport Therapeutics since September 2024. Prior to this position, Corey held multiple leadership roles at Sage Therapeutics from May 2016 to August 2024, including Executive Director and Senior Director of Regulatory Affairs. Corey's career also includes positions at Keryx Biopharmaceuticals as Associate Director of Regulatory Affairs, Alkermes as Regulatory Affairs Manager, and several other regulatory roles at Aeris Therapeutics, Inc., ViaCell, Inc., Nucryst Pharmaceuticals, and Acambis. Corey obtained a degree from Salem State University between 1998 and 2003.